Mechanisms underlying lipid emulsion resuscitation for drug toxicity: a narrative review
Korean Journal of Anesthesiology · 01.06.2023 · 76 (3) · 171-182
DOI: 10.4097/kja.23031 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Korean Journal of Anesthesiology, erschienen am 01.06.2023. Verfasst von Soo Hee Lee und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, Gyeongsang National University Changwon Hospital, Changwon, Korea. Hauptthemen laut MEDLINE: Fat Emulsions, Intravenous, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Education, National Research Foundation of Korea.
Themen: Reanimation
Abstract (Originalsprache)
Currently, lipid emulsion (LE) is widely used to treat local anesthetic systemic toxicity (LAST). LE also ameliorates intractable cardiovascular collapse caused by lipid-soluble non-local anesthetic drug toxicity. This review aims to provide the underlying mechanism of LE resuscitation in drug toxicity (including LAST) and a detailed description of LE treatment and to discuss further research directions. We searched for relevant articles using the following keywords: “local anesthetic systemic toxicity or LAST or toxicity or intoxication or poisoning” and “Intralipid or lipid emulsion”. The underlying mechanisms of LE treatment can be classified into indirect and direct effects. One indirect effect known as the lipid shuttle is a commonly accepted mechanism of LE treatment. The lipid shuttle involves the absorption of highly lipid-soluble drugs (e.g., bupivacaine) from the heart and brain through the lipid phase, which are then delivered to the muscle, adipose tissue, and liver for storage and detoxification. The direct effects include inotropic effects, fatty acid supply, attenuation of mitochondrial dysfunction, glycogen synthase kinase-3β phosphorylation, and inhibition of nitric oxide. These mechanisms appear to act synergistically to treat drug toxicity. The recommended protocol for LE treatment of LAST is as follows: a bolus administration of 20% LE at 1.5 ml/kg over 2–3 min followed by 20% LE at 0.25 ml/kg/min. LAST most commonly occurs after intravenous administration of local anesthetics. However, non-local anesthetic drugs that cause drug toxicity are orally administered. Further studies are needed to determine the optimal dosing schedule of LE treatment for non-local anesthetic drug toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Pain Medicine, Gyeongsang National University Changwon Hospital, Changwon, Korea.
- Department of Anesthesiology and Pain Medicine, Gyeongsang National University College of Medicine, Jinju, Korea.
- Institute of Health Sciences, Gyeongsang National University, Jinju, Korea.
- Department of Anesthesiology and Pain Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea.
Förderung
- Ministry of Education
- National Research Foundation of Korea
Zitieren
APA
Lee, S. H., & Sohn, J. T. (2023). Mechanisms underlying lipid emulsion resuscitation for drug toxicity: a narrative review. Korean Journal of Anesthesiology, 76(3), 171-182. https://doi.org/10.4097/kja.23031
Vancouver
Lee SH, Sohn JT. Mechanisms underlying lipid emulsion resuscitation for drug toxicity: a narrative review. Korean Journal of Anesthesiology. 2023;76(3):171-182. doi:10.4097/kja.23031
BibTeX
@article{Lee2023,
author = {Lee, Soo Hee and Sohn, Ju-Tae},
title = {Mechanisms underlying lipid emulsion resuscitation for drug toxicity: a narrative review},
journal = {Korean Journal of Anesthesiology},
year = {2023},
volume = {76},
number = {3},
pages = {171--182},
doi = {10.4097/kja.23031}
}
EUVIMED